Literature DB >> 27207425

Examining coagulation-complement crosstalk: complement activation and thrombosis.

Jonathan H Foley1.   

Abstract

The coagulation and complement systems are ancestrally related enzymatic cascades of the blood. Although their primary purposes have diverged over the past few hundred million years, they remain inextricably connected. Both complement and coagulation systems limit infection by pathogens through innate immune mechanisms. Recently, it has been shown that hyperactive complement (in particular, elevated C5a/C5b-9) is involved in the pathogenesis (including thrombosis) of diseases such as paroxysmal nocturnal hemoglobinuria, atypical haemolytic uremic syndrome, antiphospholipid syndrome and bacteremia. Although these diseases together account for many thrombosis cases, there are many more where complement activation is not considered a causative factor leading to thrombosis. To better understand what role complement may play in the pathogenesis of thrombosis a better understanding of the mechanisms that cause over-active complement in thrombotic disease is required.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coagulation; Complement; enzyme kinetics; serine proteases

Mesh:

Substances:

Year:  2016        PMID: 27207425     DOI: 10.1016/S0049-3848(16)30365-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  19 in total

Review 1.  Complementopathies.

Authors:  Andrea C Baines; Robert A Brodsky
Journal:  Blood Rev       Date:  2017-02-06       Impact factor: 8.250

2.  Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome.

Authors:  Virginie Planche; Arsene Mékinian; Théo Ghelfenstein Ferreira; François Delhommeau; Catherine Johanet; Grigorios Gerotziafas; Marie Bornes; Jonathan Cohen; Gilles Kayem; Olivier Fain
Journal:  Clin Rheumatol       Date:  2020-01-10       Impact factor: 2.980

3.  Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.

Authors:  Saravanan Subramaniam; Kerstin Jurk; Lukas Hobohm; Sven Jäckel; Mona Saffarzadeh; Kathrin Schwierczek; Philip Wenzel; Florian Langer; Christoph Reinhardt; Wolfram Ruf
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

4.  Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.

Authors:  Georg Gelbenegger; Christian Schoergenhofer; Ulla Derhaschnig; Nina Buchtele; Christian Sillaber; Michael Fillitz; Thomas M Schenk; Shirley D'Sa; Ronwyn Cartwright; James C Gilbert; Bernd Jilma; Ulrich Jaeger
Journal:  Blood Adv       Date:  2020-03-24

Review 5.  Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.

Authors:  Hiroyuki Horiguchi; Tyler J Loftus; Russell B Hawkins; Steven L Raymond; Julie A Stortz; McKenzie K Hollen; Brett P Weiss; Elizabeth S Miller; Azra Bihorac; Shawn D Larson; Alicia M Mohr; Scott C Brakenridge; Hironori Tsujimoto; Hideki Ueno; Frederick A Moore; Lyle L Moldawer; Philip A Efron
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

6.  Differences in responses of grass carp to different types of grass carp reovirus (GCRV) and the mechanism of hemorrhage revealed by transcriptome sequencing.

Authors:  Libo He; Aidi Zhang; Yongyan Pei; Pengfei Chu; Yongming Li; Rong Huang; Lanjie Liao; Zuoyan Zhu; Yaping Wang
Journal:  BMC Genomics       Date:  2017-06-08       Impact factor: 3.969

7.  Complement component 5 promotes lethal thrombosis.

Authors:  Tomohiro Mizuno; Kengo Yoshioka; Masashi Mizuno; Mie Shimizu; Fumihiko Nagano; Tomoyuki Okuda; Naotake Tsuboi; Shoichi Maruyama; Tadashi Nagamatsu; Masaki Imai
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

Review 8.  Plasmin, Immunity, and Surgical Site Infection.

Authors:  Stuart Hastings; Paul S Myles; Robert L Medcalf
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

9.  Ischemic Stroke: An Underestimated Complication of COVID-19.

Authors:  Wen Cao; Cong Zhang; Huan Wang; Qianqian Wu; Yujia Yuan; Junmin Chen; Shuo Geng; Xiangjian Zhang
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

10.  Alternative Complement Pathway Activation Provokes a Hypercoagulable State with Diminished Fibrinolysis.

Authors:  Jason M Samuels; Julia R Coleman; Ernest E Moore; Matt Bartley; Navin Vigneshwar; Mitchell Cohen; Christopher C Silliman; Angela Sauaia; Anirban Banerjee
Journal:  Shock       Date:  2020-05       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.